Thu, February 11, 2021
Wed, February 10, 2021
Tue, February 9, 2021
Mon, February 8, 2021
Sat, February 6, 2021
Fri, February 5, 2021
Thu, February 4, 2021

Puneet Souda Maintained (ABCL) at Buy with Increased Target to $52 on, Feb 8th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-52-on-feb-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Increased Target from $45 to $52 on, Feb 8th, 2021.

Puneet has made no other calls on ABCL in the last 4 months.



There are 4 other peers that have a rating on ABCL. Out of the 4 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Puneet


  • Do Kim of "BMO Capital" Initiated at Buy and Held Target at $48 on, Tuesday, January 5th, 2021
  • Gal Munda of "Berenberg" Initiated at Strong Buy and Held Target at $53 on, Tuesday, January 5th, 2021
  • Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $59 on, Tuesday, January 5th, 2021
  • Tiago Fauth of "Credit Suisse" Initiated at Buy on, Tuesday, January 5th, 2021

Publication Contributing Sources